Drug Profile
Research programme: anti-MICA monoclonal antibody - Innate Pharma
Alternative Names: IPH-4301Latest Information Update: 28 Mar 2019
Price :
$50
*
At a glance
- Originator Innate Pharma
- Class Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Natural killer cell receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer